Michelle Xia represents a rising generation of biotech companies in China challenging Western giants.

Kailera jumped the weight loss miracle-drug line by licensing four clinical-stage obesity therapies from China, which is ...

However, international brokerage CLSA allayed concerns, stating that the risk of high tariffs on pharma products is low. “The pharma is going to be starting to come in at, I think, a level that ...

LINCOLNSHIRE, Ill.--(BUSINESS WIRE)--Nexus Pharmaceuticals, LLC announced the launch of Tranexamic Acid. This milestone is another step for Nexus in its mission to provide life-saving medication ...

Careful vulnerability assessments on various pharmaceutical product categories should be conducted to enable policymakers to identify the targeted supply chain policy interventions best suited to ...

Rhythm Pharmaceuticals said on Monday its drug Imcivree notably reduced weight in patients with a rare obesity disorder caused by damage to the brain, meeting the main goal of a late-stage trial.

Nexus Pharmaceuticals, LLC announced the launch of Tranexamic Acid. This milestone is another step for Nexus in its mission to provide life-saving medication to those who need it most. “We are ...

Some scientists assigned double the number of new product applications for review Some deadlines for tobacco products will not be met and the start of new applications have been delayed ...

Product sensitivity. Many pharmaceutical products are highly sensitive to environmental factors, requiring strict temperature and humidity controls, shock detection, and protection from contaminants.

Looking ahead, this article highlights the key trends expected to shape the regulatory landscape of pharmaceutical manufacturing ... offer greater flexibility in product development and lifecycle ...

Sanofi's Qfitlia gains FDA approval, offering fewer injections in hemophilia care. Check out my recommendation for SNY stock.